July 7, 2017
Topline results from the REVEAL (Randomized EValuation of the Effects of Anacetrapib through Lipid modification) study have given new hope to cholesteryl ester transfer protein (CETP) inhibitors.
CETP inhibitors initially gained much interest for their potent ability to...
Vaz Vision (3)
MEDUCOM goes axe throwing!
December 12, 2019
Ontario pharmacists expected to diagnose and prescribe for common ailments
November 28, 2019
Helping the Season Shine a Little Brighter
November 22, 2019
The future of celiac disease: Takeda acquires licence to investigational first-in-class therapy
November 15, 2019
World Diabetes Day
November 14, 2019
A Case of the Blues: Is Screen Time Linked to Decreased Longevity?
November 1, 2019
World Psoriasis Day
October 29, 2019
What does the election mean for pharmacare?
October 25, 2019
MEDUCOM Takes on a Maize Maze!
October 24, 2019
October 20th was World Osteoporosis Day
October 21, 2019